Evaluation of an alternative S100b assay for use in cardiac surgery: Relationship with microemboli and neuropsychological outcome

Perfusion

Volumn 22, Issue 4, 2007, Pages 267-272

  Whitaker, D C ^a   Green, A J E ^b,d   Stygall, J ^a   Harrison, M J G ^c   Newman, Stanton P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN S 100; PROTEIN S100B;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN DAMAGE; BRAIN EMBOLISM; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROEMBOLISM; MIDDLE CEREBRAL ARTERY; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SUCTION; VENOUS BLOOD;

EID: 36749103169     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659107083243     Document Type: Article

References (24)

1. Newman S, Stygall J. Changes in cognition following cardiac surgery. Heart 1999; 82: 541-42.
2. Ali MS, Harmer M, Vaughan R. Serum S100 protein as a marker of cerebral damage during cardiac surgery. Br J Anaesth 2000; 85: 287-98.
3. Vaage J, Anderson R. Biochemical markers of neurologic injury in cardiac surgery: the rise and fall of S100beta. J Thorac Cardiovasc Surg 2001; 122: 853-5.
4. Georgiadis D, Berger A, Kowatschev E, et al. Predictive value of S-100beta and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery. J Thorac Cardiovasc Surg 2000; 119: 138-47.
5. Kilminster S, Treasure T, McMillan T, Holt DW. Neuropsychological change and S-100 protein release in 130 unselected patients undergoing cardiac surgery. Stroke 1999; 30: 1869-74.
6. Westaby S, Saatvedt K, White S et al. Is there a relationship between serum S-100beta protein and neuropsychologic dysfunction after cardiopulmonary bypass? J Thorac Cardiovasc Surg 2000; 119: 132-37.
7. Pisa EK. Serum S-100 protein in stroke and cardiac surgery. Stroke 1999; 30: 1153-54.
8. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull 1995; 37: 417-29.
9. Fazio V, Bhudia SK, Marchi N, Aumayr B, Janigro D. Peripheral detection of S100beta during cardiothoracic surgery: what are we really measuring? Ann Thorac Surg 2004; 78: 46-52; discussion 52-43.
10. Jonsson H, Johnsson P, Alling C, Backstrom M, Bergh C, Blomquist S. S100beta after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg 1999; 68: 2202-08.
11. Petzold A, Keir G, Lim D, Smith M, Thompson EJ. Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. Brain Res Bull 2003; 61: 281-85.
12. Green AJ, Keir G, Thompson EJ. A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid. J Immunol Methods 1997; 205: 35-41.
13. Whitaker DC, Newman SP, Stygall J, Hope-Wynne C, Harrison MJ, Walesby RK. The effect of leucocyte-depleting arterial line filters on cerebral microemboli and neuropsychological outcome following coronary artery bypass surgery. Eur J Cardiothorac Surg 2004; 25: 267-74.
14. Ringelstein EB, Droste DW, Babikian VL et al. Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection. Stroke 1998; 29: 725-29.
15. Kong RS, Butterworth J, Aveling W et al. Clinical trial of the neuroprotectant clomethiazole in coronary artery bypass graft surgery: a randomized controlled trial. Anesthesiology 2002; 97: 585-91.
16. Anderson RE, Hansson LO, Vaage J. Release of S100B during coronary artery bypass grafting is reduced by off-pump surgery. Ann Thorac Surg 1999; 67: 1721-25.
17. Steed L, Kong R, Stygall J et al. The role of apolipoprotein E in cognitive decline after cardiac operation. Ann Thorac Surg 2001; 71: 823-26.
18. Arrowsmith JE, Harrison MJ, Newman SP, Stygall J, Timberlake N, Pugsley WB. Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke 1998; 29: 2357-62.
19. Van Dijk D, Jansen EW, Hijman R et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial. Jama 2002; 287: 1405-12.
20. Selnes OA, Grega MA, Borowicz LM, Jr., Royall RM, McKhann GM, Baumgartner WA. Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls. Ann Thorac Surg 2003; 75: 1377-84; discussion 1384-86.
21. Stygall J, Newman SP, Fitzgerald G et al. Cognitive change 5 years after coronary artery bypass surgery. Health Psychol 2003; 22: 579-86.
22. Selnes OA, Royall RM, Grega MA, Borowicz LM, Jr., Quaskey S, McKhann GM. Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline? Arch Neurol 2001; 58: 598-604.
23. Whitaker D. The use of Z scores in assessing neuropsychological change after cardiac operations. Ann Thorac Surg 2003; 75: 1066; author reply 1066-67.
24. Anderson RE, Hansson LO, Liska J, Settergren G, Vaage J. The effect of cardiotomy suction on the brain injury marker S100beta after cardiopulmonary bypass. Ann Thorac Surg 2000; 69: 847-50.